Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictive value of ERCC2, ABCC2 and MMP2 of response and long-term survival in locally advanced head and neck cancer patients treated with chemoradiotherapy.
Duran G, Cruz R, Aguín S, Barros F, Giráldez JM, Bernárdez B, Zarra I, López-López R, Carracedo Á, Lamas MJ. Duran G, et al. Among authors: aguin s. Cancer Chemother Pharmacol. 2021 Nov;88(5):813-823. doi: 10.1007/s00280-021-04330-1. Epub 2021 Jul 26. Cancer Chemother Pharmacol. 2021. PMID: 34309735
Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients.
Mondelo-Macía P, Rodríguez-López C, Valiña L, Aguín S, León-Mateos L, García-González J, Abalo A, Rapado-González O, Suárez-Cunqueiro M, Díaz-Lagares A, Curiel T, Calabuig-Fariñas S, Azkárate A, Obrador-Hevia A, Abdulkader I, Muinelo-Romay L, Diaz-Peña R, López-López R. Mondelo-Macía P, et al. Among authors: aguin s. Cells. 2020 Feb 24;9(2):522. doi: 10.3390/cells9020522. Cells. 2020. PMID: 32102486 Free PMC article.
Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non-small-cell lung cancer treated with pembrolizumab.
Mondelo-Macía P, García-González J, León-Mateos L, Anido U, Aguín S, Abdulkader I, Sánchez-Ares M, Abalo A, Rodríguez-Casanova A, Díaz-Lagares Á, Lago-Lestón RM, Muinelo-Romay L, López-López R, Díaz-Peña R. Mondelo-Macía P, et al. Among authors: aguin s. Mol Oncol. 2021 Nov;15(11):2923-2940. doi: 10.1002/1878-0261.13094. Epub 2021 Sep 23. Mol Oncol. 2021. PMID: 34465006 Free PMC article.
Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment.
Muinelo-Romay L, Vieito M, Abalo A, Nocelo MA, Barón F, Anido U, Brozos E, Vázquez F, Aguín S, Abal M, López RL. Muinelo-Romay L, et al. Among authors: aguin s. Cancers (Basel). 2014 Jan 21;6(1):153-65. doi: 10.3390/cancers6010153. Cancers (Basel). 2014. PMID: 24452143 Free PMC article.
Insights into the Use of Peripherally Acting μ-Opioid Receptor Antagonists (PAMORAs) in Oncologic Patients: from Scientific Evidence to Real Clinical Practice.
Fernández-Montes A, de Velasco G, Aguín S, Farriols C, Guirado-Risueño M, Jerviz-Guía VG, Baeza-Nadal MV, Chicas-Sett R, Fírvida JL, García-Navalón F, Martín P, Perezagua-Marín C, Rodríguez D, Santamaría J, Saurí T, Cobo M. Fernández-Montes A, et al. Among authors: aguin s. Curr Treat Options Oncol. 2021 Feb 26;22(3):26. doi: 10.1007/s11864-021-00816-5. Curr Treat Options Oncol. 2021. PMID: 33635493 Review.
Injury-Induced Senescence Enables In Vivo Reprogramming in Skeletal Muscle.
Chiche A, Le Roux I, von Joest M, Sakai H, Aguín SB, Cazin C, Salam R, Fiette L, Alegria O, Flamant P, Tajbakhsh S, Li H. Chiche A, et al. Among authors: aguin sb. Cell Stem Cell. 2017 Mar 2;20(3):407-414.e4. doi: 10.1016/j.stem.2016.11.020. Epub 2016 Dec 22. Cell Stem Cell. 2017. PMID: 28017795 Free article.